An aging-population, threat of antibiotic-resistant bacteria, high-burden diseases: how can we deal with these problems? There is an unmet need for medical solutions. In AIMMS we have the ideal combinations of excellent researchers, expertise and technology platforms to work on innovative development of new small molecule drugs, other therapeutics and diagnostic strategies.
How to reach fundamental breakthroughs in translational medicine? One starting point is looking at the molecules, better understanding of how they act and behave in a biological surrounding. Development of new diagnostic tools, discovery of small drug molecules, optimization of therapeutics, it all starts with the description in detail of molecule – (bio)molecule interactions and prediction of their behaviour.
No explanation is needed to see that the society is waiting for new drugs, better drugs, drugs with less side effects, innovative therapeutics. In AIMMS we work on this discovery, development and safety. Better understanding of mechanisms of diseases combined with different approaches will bring us a huge step forward.
How to solve traffic jams in the biology? Verify the botlle necks using a system approach to describe complex networking bio-molecules. Select bio-markers out of large databases and couple this to experimental data. That will be tomorrow's way of working on solutions for the health and disease problems of today. In AIMMS we have started already.
- Top rating for Master involving AIMMS researchers
- Grassroots innovation grant to exploring readily accessible virtual reality in (bio)molecular education
- Pharmaceutical Sciences student VU Amsterdam wins PAC poster prize
- Eelco Ruijter receives NWO ECHO grant
- Célia Fonseca Guerra Extraordinary Professor at Leiden University
- Medicinal Chemists AIMMS develop Virtual Machine for Computer-Aided Drug Discovery
- Matthias Bickelhaupt in PNAS with 8-Coordinate Fluoride